Praćenje remisije kronične mijeloične leukemije nakon prekida terapije

Matić, Nikolina

prikaz prve stranice dokumenta Praćenje remisije kronične mijeloične leukemije nakon prekida terapije

Download
PDF 1.72 MB

master's thesis

Praćenje remisije kronične mijeloične leukemije nakon prekida terapije

Zagreb: University of Zagreb, School of Medicine, 2017. urn:nbn:hr:105:527097

Matić, Nikolina

University of Zagreb
School of Medicine
Department of Internal Medicine

Cite this document

APA 6th Edition

Matić, N. (2017). Praćenje remisije kronične mijeloične leukemije nakon prekida terapije (Master's thesis). Zagreb: University of Zagreb, School of Medicine. Retrieved from https://urn.nsk.hr/urn:nbn:hr:105:527097

MLA 8th Edition

Matić, Nikolina. "Praćenje remisije kronične mijeloične leukemije nakon prekida terapije." Master's thesis, University of Zagreb, School of Medicine, 2017. https://urn.nsk.hr/urn:nbn:hr:105:527097

Chicago 17th Edition

Matić, Nikolina. "Praćenje remisije kronične mijeloične leukemije nakon prekida terapije." Master's thesis, University of Zagreb, School of Medicine, 2017. https://urn.nsk.hr/urn:nbn:hr:105:527097

Harvard

Matić, N. (2017). 'Praćenje remisije kronične mijeloične leukemije nakon prekida terapije', Master's thesis, University of Zagreb, School of Medicine, accessed 18 April 2024, https://urn.nsk.hr/urn:nbn:hr:105:527097

Vancouver

Matić N. Praćenje remisije kronične mijeloične leukemije nakon prekida terapije [Master's thesis]. Zagreb: University of Zagreb, School of Medicine; 2017 [cited 2024 April 18] Available at: https://urn.nsk.hr/urn:nbn:hr:105:527097

IEEE

N. Matić, "Praćenje remisije kronične mijeloične leukemije nakon prekida terapije", Master's thesis, University of Zagreb, School of Medicine, Zagreb, 2017. Available at: https://urn.nsk.hr/urn:nbn:hr:105:527097

Cite this item: https://urn.nsk.hr/urn:nbn:hr:105:527097

Please login to the repository to save this object to your list.

Metadata

Title	Praćenje remisije kronične mijeloične leukemije nakon prekida terapije
Title (english)	Chronic myeloid leukemia remission follow up after therapy discontinuation
Author	Nikolina Matić
Mentor	Ana Boban (mentor)
Committee member	Nadira Duraković (predsjednik povjerenstva)
Committee member	Marko Jakopović (član povjerenstva)
Committee member	Ana Boban (član povjerenstva)
Granter	University of Zagreb School of Medicine (Department of Internal Medicine) Zagreb
Defense date and country	2017-09-28, Croatia
Scientific / art field, discipline and subdiscipline	BIOMEDICINE AND HEALTHCARE Clinical Medical Sciences Internal Medicine
Abstract	Kronična mijeloična leukemija (KML) specifična je zloćudna bolest s obzirom da je liječenje moguće provoditi peroralnim uzimanjem lijekova. Liječenje KML-a se bazira na dugogodišnjoj terapiji inhibitorima tirozin kinaze (TKI). Redovitom i pravilnom upotrebom ovog lijeka veliki broj bolesnika postiže remisiju bolesti, pri čemu je u uspjehu liječenja iznimno važan čimbenik suradljivost bolesnika u odnosu na redovitu primjenu lijeka i medicinske kontrole. Rutinska praksa podrazumijeva korištenje TKI i nakon što bolesnik postigne potpunu remisiju bolesti, no recentna znanstvena istraživanja navode uspjeh u održavanju zdravstvenog stanja i kontroli bolesti i nakon što se prekine terapija s TKI. Svrha ovoga rada je sustavnim pregledom literature prikupiti relevantne znanstvene činjenice o uspješnosti održavanja remisije KML nakon prekida terapije TKI.
Abstract (english)	Chronic myeloid leukaemia (CML) is a specific malignant disease as it can be managed by oral treatment. The patients with CML are treated by a long term tyrosine-kinase inhibitors (TKI). The remission of the disease can be achieved in majority of patients, and the tretment results depend largely on patient's compliance and regular taking of TKI. Current routine practise in themanagement of CML includes continuation of TKI therapy even after patient achieves deep remision. However, recent studies suggested that the disease can remain in remision even after the TKI discontinuation. The aim of this thesis is to asses of relevant scientific evidence on CML remission stability after TKI therapy cessation.
Keywords
Keywords (english)
Language	croatian
URN:NBN	urn:nbn:hr:105:527097
Study programme	Title: Studies in Nursing Study programme type: university Study level: graduate Academic / professional title: magistar/magistra sestrinstva (magistar/magistra sestrinstva)
Type of resource	Text
File origin	Born digital
Access conditions	Open access
Terms of use
Repository	Dr Med - University of Zagreb School of Medicine Digital Repository
Created on	2018-03-21 11:06:21

Nacionalna i sveučilišna knjižnica u Zagrebu

Dabar